Leishmaniases: Epidemiological Report in the Americas, No. 1 (April 2013)
MetadataShow full item record
Other Language Versions
[Presentation]. Leishmaniases are present in all continents and are endemic in 98 countries, with more than 350 million people at risk. In the Americas, leishmaniases represents a significant public health problem due to its high morbidity and wide geographic distribution. Its complex transmission cycle includes different species of parasites, vectors and reservoirs. Poor populations with difficult access to health services are most affected. Strengthening surveillance and disease control against leishmaniases was taken as a commitment by countries in the World Health Assembly, Resolution WHA 60.13, 2007. This commitment was reinforced in the Americas, by Pan American Health Organization (PAHO) Directing Council through the adoption of Resolution CD49.R19,2009. The PAHO through the Regional Program on Leishmaniases contributes technical cooperation to the countries of the region.In particular, the Regional Program aims to improving access to diagnosis and treatment of affected persons, strengthening surveillance and control activities and processes for decision making, building capacity, and advancing communication between local health professionals and managers within the region. This report presents the epidemiological situation of leishmaniases in the region and is a joint effort of the National Programs on leishmaniases. Despite some data limitations, a number of epidemiological parameters can be analyzed and discussed to inform efforts for the improvement of leishmaniases surveillance in the Americas.
Table of contents
Presentation | Introduction | Epidemiological situation: Cutaneous and mucosal leishmaniasis; Visceral leishmaniasis | Final remarks | Acknowledgements
Category of PAHO Strategic Plan 2014-2019
Showing items related by title, author, creator and subject.
Leishmaniases: Epidemiological Report in the Americas, No. 2 (June 2014) Pan American Health Organization; Communicable Diseases and Environmental Determinants of Health (CDE) (Washington, D.C., PAHO, 2014-06-01)[Presentation]. The strengthening health surveillance of leishmaniases in the Americas is one of the goals of the Regional Program of Leishmaniases of the Pan American Health Organization - World Health Organization ...
Leishmaniasis: Epidemiological Report for the Americas. No.11 (December 2022) Pan American Health Organization; Communicable Diseases and Environmental Determinants of Health (CDE) (Washington, D.C., PAHO, 2022-12-08)This report presents a detailed analysis of 2021 data on leishmaniases in the Region of the Americas and includes a series of infographics with specific data on cutaneous and mucosal leishmaniasis in endemic countries. In ...
Leishmaniases. Epidemiological Report in the Americas, July 2016 Pan American Health Organization (Washington, D.C., PAHO, 2016-07)[Introduction]. The leishmaniases are vector-borne diseases with a zoonotic cycle in the Americas and remain a problem to public health. This disease presents a high burden capable of yielding severe clinical forms that ...